Skip Nav Destination
Close Modal
Search Results for
macular
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Book Series
Date
Availability
1-20 of 1042 Search Results for
macular
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Book Chapter
Series: Developments in Ophthalmology
Volume: 37
Published: 18 June 2003
10.1159/000072045
EISBN: 978-3-318-00971-2
Book Chapter
Series: Developments in Ophthalmology
Volume: 29
Published: 12 November 1997
10.1159/000060726
EISBN: 978-3-318-00252-2
Book Chapter
Series: Developments in Ophthalmology
Volume: 5
Published: 18 March 1982
10.1159/000400951
EISBN: 978-3-318-03536-0
Book Chapter
Series: ESASO Course Series
Volume: 11
Published: 28 December 2020
10.1159/000485295
EISBN: 978-3-318-06643-2
... Abstract Dry age-related macular degeneration (AMD) is characterized by changes in the outer retina, retinal pigment epithelium (RPE), and choroid. Optical coherence tomography angiography (OCTA) has proven instrumental in analyzing these changes and further understanding the pathogenesis...
Book Chapter
Series: ESASO Course Series
Volume: 11
Published: 28 December 2020
10.1159/000485296
EISBN: 978-3-318-06643-2
... Abstract Age-related macular degeneration (AMD) is the most common cause of central vision loss in developed nations and its prevalence has been progressively increasing over the years. Although many factors have been shown to be involved in AMD pathogenesis, it is well established...
Book Chapter
Series: ESASO Course Series
Volume: 11
Published: 28 December 2020
10.1159/000485299
EISBN: 978-3-318-06643-2
... Abstract Early detection of neovascular age-related macular degeneration is vitally important so that treatment with vascular endothelial growth factor inhibitors can be initiated as soon as symptomatic exudation arises. Swept-source optical coherence tomography angiography (SS-OCTA...
Book Chapter
Series: ESASO Course Series
Volume: 11
Published: 28 December 2020
10.1159/000504906
EISBN: 978-3-318-06643-2
... Abstract Macular telangiectasis encompasses different clinical entities characterized by telangiectatic alterations of the parafoveal retinal capillary plexa involving one or both eyes with different pathogenesis, appearance, and therapeutic response. Diagnosis is mainly based on multimodal...
Book Chapter
Series: ESASO Course Series
Volume: 11
Published: 28 December 2020
10.1159/000504924
EISBN: 978-3-318-06643-2
... Abstract Age-related macular degeneration (AMD) is the leading cause of visual impairment in adults over the age of 55 years in industrialized countries. The intermediate stage of AMD is defined by the presence of large drusen and/or AMD pigmentary abnormalities on funduscopic examination...
Book Chapter
Series: ESASO Course Series
Volume: 9
Published: 07 June 2017
10.1159/000471824
EISBN: 978-3-318-06068-3
... Abstract Age-related macular degeneration (AMD) is one of the main causes of visual deterioration in the developed nations. AMD comes in many forms but the most devastating form is the exudative (wet) type. Over the years, research into the pathophysiology of AMD has led to the discovery...
Book Chapter
Series: ESASO Course Series
Volume: 9
Published: 07 June 2017
10.1159/000471825
EISBN: 978-3-318-06068-3
... Abstract Neovascular age-related macular degeneration (AMD) is a disease with the potential to cause significant visual impairment. The hallmark of this disease is the development of angiogenesis originating from the choroid or retina leading to various, potentially blinding, complications...
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000460496
EISBN: 978-3-318-06042-3
... Abstract Intravitreal ranibizumab (RBZ) has been shown in multiple randomized clinical trials to be a valuable treatment for diabetic macular edema (DME), promoting a significant improvement in best-corrected visual acuity (BCVA) and in anatomic outcomes. Compared to sham (RISE and RIDE studies...
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000460220
EISBN: 978-3-318-06042-3
... Abstract For decades, macular laser photocoagulation has been the standard of care in the treatment of diabetic macular edema (DME). With the relatively recent advent of anti-vascular endothelial growth factor (VEGF) agents, DME treatment has entered a new era. VEGF is a well-known pro...
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000459691
EISBN: 978-3-318-06042-3
... Abstract Over the past decade, great strides have been made in the management of diabetic macular edema (DME). Therapeutic alternatives now include focal/grid laser photocoagulation, vitreo-retinal surgery, and intraocular injection of anti-angiogenic and steroid molecules. Intravitreal...
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000459692
EISBN: 978-3-318-06042-3
... for the treatment of center-involving diabetic macular edema (DME). A total of 854 adult patients with type I or II diabetes and any level of non-proliferative diabetic retinopathy or proliferative retinopathy with adequate panretinal photocoagulation, with best-corrected visual acuity (BCVA) of 78 to 24 ETDRS...
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000459694
EISBN: 978-3-318-06042-3
... comparing aflibercept, bevacizumab, and ranibizumab as treatment option for center-involving diabetic macular edema (DME). The main outcome measures were change in visual acuity (VA), central subfield thickness (CST) on optical coherence tomography, cost effectiveness, burden of care, and safety. Results...
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000459696
EISBN: 978-3-318-06042-3
... Abstract Laser treatment was used in the past to reduce the visual loss due to diabetic macular edema. The recent advent of anti-vascular endothelial growth factor (anti-VEGF) has completely revolutionized the management of diabetic retinopathy, with a significant improvement in the overall...
Book Chapter
Series: Developments in Ophthalmology
Volume: 60
Published: 24 April 2017
10.1159/000459706
EISBN: 978-3-318-06042-3
... Abstract Diabetic macular edema (DME) is the most common cause of vision loss in diabetic patients, and its management is often a long process requiring frequent monitoring and therapeutic interventions. During the past several decades, numerous treatments have been developed for the treatment...
Book Chapter
Book: Macular Edema
Series: Developments in Ophthalmology
Volume: 58
Published: 24 April 2017
10.1159/000455264
EISBN: 978-3-318-06033-1
... Abstract Macular edema is the result of an accumulation of fluid in the retinal layers around the fovea. It contributes to vision loss by altering the functional cell relationship in the retina and promoting an inflammatory reparative response. Macular edema may be intracellular...
Book Chapter
Book: Macular Edema
Series: Developments in Ophthalmology
Volume: 58
Published: 24 April 2017
10.1159/000455269
EISBN: 978-3-318-06033-1
... Abstract OCT angiography is a promising new method to visualize the retinal vasculature and choroidal vascular layers in the macular area and provides depth resolved functional information of the blood flow in the vessels. Given that the main moving elements in the eye fundus are contained...
Book Chapter
Book: Macular Edema
Series: Developments in Ophthalmology
Volume: 58
Published: 24 April 2017
10.1159/000455275
EISBN: 978-3-318-06033-1
... Abstract Macular edema represents the end-stage of multiple pathophysiological pathways in a multitude of ocular vascular, inflammatory, and other diseases. The rationale for clinical treatment of macular edema is based on the understanding and the inhibition of these pathophysiological...
1